ÂÜÀòÂÒÂ×

Gary Gordon is a Venture Advisor at Israel Biotech Fund. Gary is an accomplished pharmaceutical executive and strategic business leader with extensive experience in the development of drugs from first-in-human studies to approval and commercialization.

He brings innovative approaches to the process, leveraging advantageous regulatory pathways and close collaborations with investigators, patient advocacy groups, and key academic and government consortiums.

Dr. Gordon served as the Vice President of the Oncology Department at AbbVie (a spin-off of Abbott), where he oversaw the development of AbbVie’s oncology projects. Dr. Gordon was on the Abbvie-Genentech team that received the 2017 Prix Galien award for the Best Pharmaceutical Product.

Dr. Gordon received his undergraduate education at the State University of Stony Brook and his M.D and Ph.D. from The Johns Hopkins University School of Medicine.